Abstract
Background Renal anemia, one important component of anemia, has inflicted a certain degree of loss on global health. However, there are no systematically analyses on the burden of renal anemia.
Methods We analyzed global prevalence and years lived with disability (YLDs) of renal anemia from 1990 to 2021. Based on the Socio-demographic Index, combined with cross-national inequality analysis, frontier analysis and age-period-cohort (APC) model analysis, the prevalence and YLDs differences between different genders, ages, periods, cohorts, or regions with different levels of development were compared.
Findings In 2021, the global prevalence of renal anemia across all age groups was 0.81%, resulting in 1.70 million YLDs, showing an increase compared to 1990. In recent years, chronic kidney disease has risen in rank among causes of anemia. The burden of renal anemia is particularly severe among populations over 65 years of age in Central Asia, South Asia, Southeast Asia, and Western Sub-Saharan Africa. A series of analyses based on the SDI revealed a negative correlation between the age-standardized prevalence and YLDs of renal anemia and SDI.
Interpretation Although the global burden of anemia is decreasing, the burden of renal anemia is still increasing, especially among elderly populations in low-middle and low SDI countries. Targeted programs should be implemented, starting with enhancing diagnosis and treatment in specific regions and populations. The development of new medications should also be considered.
Funding National Natural Science Foundation of China; Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China; Fujian Provincial Natural Science Foundation; Fujian Provincial Health Technology Project; Medical Discipline Construction Project of Pudong Health Committee of Shanghai.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Natural Science Foundation of China [No. 82074166], Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China [No. LHDMZ24H050001], Fujian Provincial Natural Science Foundation [No. 2018J01121], Fujian Provincial Health Technology Project [No. 2020GGA026], and Medical Discipline Construction Project of Pudong Health Committee of Shanghai [No. PWYts2021-18]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study used only publicly available human data originally located at: https://vizhub.healthdata.org/gbd-results/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Data Availability
All data produced in the present study are available upon reasonable request to the authors All data produced in the present work are contained in the manuscript All data produced are available online at: https://vizhub.healthdata.org/gbd-results/
